Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350
·
clinicaltrials.gov ↗
COMPLETED
Status
1106
Enrollment
INDUSTRY
Sponsor class
Conditions
Mutation
Neoplasms
Interventions
GENETIC:
ctDNA Analysis for the Detection of Genetic Mutations
Sponsor
Pathway Genomics